Here are five things to know:
1. Nine ratings firms covering AmSurg stock provided the “buy ” rating.
2. Christopher Holden, CEO of AmSurg, sold 3,000 shares of stock on June 3.
3. Shares were sold at an average price of $60.09 for a total transaction worth $207,060.
4. AmSurg shares traded up 0.23 percent last Thursday, reaching $70.36.
5. The stock has a 50-day moving average of $69.27 and a 200-day moving average of $61.66. The market cap is $3.35 billion.
For more ASC news:
38 spine-driven ASCs to know | 2015
Go beyond analytics: How business intelligence can make ASCs more money (Part 2)
Opportunities during times of change: Key strategies for orthopedic centers
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
